University of Kansas School of Medicine Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 127
• Hematopoietic Stem Cell Transplantation 114
• CAR-T cell therapy research 104
• Multiple Myeloma Research and Treatments 90
• Breast Cancer Treatment Studies 62
• Myeloproliferative Neoplasms: Diagnosis and Treatment 54
• Cancer Immunotherapy and Biomarkers 48
• Colorectal Cancer Treatments and Studies 47
• Prostate Cancer Treatment and Research 47
• Lymphoma Diagnosis and Treatment 44
• Renal cell carcinoma treatment 42
• Pancreatic and Hepatic Oncology Research 36

Most cited

1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 1,350 citations · Joseph McGuirk

2. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Benjamin Powers, Gary Doolittle

3. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 447 citations · Prakash Neupane

4. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.

   The New England journal of medicine · 2021 · 751 citations · Priyanka Sharma

5. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Joseph McGuirk

6. Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

   The New England journal of medicine · 2023 · 409 citations ·